Is a testosterone level of 32.5 ng/dL normal for a 35‑year‑old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is a Testosterone Level of 32.5 ng/dL Normal for a 35-Year-Old Woman?

A testosterone level of 32.5 ng/dL in a 35-year-old woman falls within the normal range and does not indicate hyperandrogenism or require intervention unless accompanied by clear clinical signs of androgen excess.

Understanding Normal Testosterone Ranges in Women

The interpretation of this value depends critically on understanding established reference ranges for premenopausal women. According to validated research using proper immunoassays in normally cycling premenopausal women, the 5th to 95th percentile reference range for total testosterone in a 30-year-old woman is 15-46 ng/dL 1. Your patient's value of 32.5 ng/dL falls comfortably in the middle of this range.

A more recent large-scale analysis of 5,323 women aged 19-59 years with normal BMI and regular cycles confirms that testosterone levels in this range are physiologically normal 2. The study demonstrates that testosterone decreases with age in women, but a level of 32.5 ng/dL at age 35 represents a typical value.

Critical Laboratory Considerations

You must verify which assay method your laboratory used, as this significantly impacts interpretation. The AACE guidelines emphasize that many commercial laboratories provide inaccurate normal ranges for female testosterone, with some laboratories reporting the same sample value as normal while others flag it as abnormal 3. Research demonstrates that most hyperandrogenic women have testosterone levels >50 ng/dL, while most normal women have levels <40 ng/dL 4. Your patient's value of 32.5 ng/dL clearly falls in the normal category.

The Endocrine Society guidelines stress that automated immunoassays available in most hospital laboratories are often unsuitable for accurately measuring testosterone in women, and specialty laboratories using validated assays or mass spectrometry methods provide more reliable results 5.

When to Investigate Further

Investigate only if clinical signs of hyperandrogenism are present:

  • Hirsutism (male-pattern hair growth, Ferriman-Gallwey score assessment)
  • Menstrual irregularities (oligomenorrhea >35 days, amenorrhea >6 months)
  • Severe acne (seborrheic, treatment-resistant)
  • Virilization signs (clitoromegaly, voice deepening, male escutcheon)

The AACE guidelines specify that testosterone measurement should be obtained during the first 7 days of the menstrual cycle in fasting conditions for optimal accuracy 3. While testosterone shows a modest midcycle increase, this variation is small compared to overall variability and doesn't significantly affect clinical interpretation 1.

Additional Testing Only If Clinically Indicated

If your patient has symptoms of hyperandrogenism despite this normal testosterone level, consider:

  • Free testosterone or calculated free testosterone - More sensitive for detecting subtle hyperandrogenemia, particularly in obese women with reduced SHBG due to hyperinsulinemia 3, 5
  • DHEAS - If >600 μg/dL (16,000 nmol/L), suggests adrenal source and warrants imaging 6
  • 17-hydroxyprogesterone - Only in high-risk ethnic groups (Ashkenazi Jews, Hispanics, Slavics) to exclude nonclassic congenital adrenal hyperplasia 5
  • LH, FSH, prolactin - If menstrual irregularities present 3, 7

Common Pitfalls to Avoid

  1. Do not rely on commercial laboratory reference ranges - Many provide excessively broad ranges (10-90 ng/dL) that incorrectly classify hyperandrogenic women as normal 4

  2. Do not order free testosterone by direct immunoassay - These assays are seriously flawed; calculate free testosterone from total testosterone and SHBG instead 8

  3. Do not investigate asymptomatic women - Testosterone levels alone without clinical signs do not warrant treatment or further workup 3

  4. Recognize that women over 35 may not show hyperandrogenemia even with clinical signs - Ovarian androgen production decreases with aging, so hirsutism may persist despite normalizing testosterone levels 3

Bottom Line

No action is required for this patient unless she exhibits clinical signs of hyperandrogenism. A testosterone level of 32.5 ng/dL at age 35 represents a normal physiologic value. Document the result, reassure the patient if this was checked for screening purposes, and focus your clinical assessment on whether any symptoms of androgen excess are actually present before pursuing additional testing.

References

Research

Redefining testosterone reference ranges for adult females.

Journal of endocrinological investigation, 2026

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Research

Utilization of commercial laboratory results in management of hyperandrogenism in women.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 1998

Guideline

recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

Guideline

reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

Journal of Neurology, Neurosurgery and Psychiatry, 2002

Guideline

androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

Related Questions

Is a testosterone level of 18 ng/dL in a 48‑year‑old woman within the normal reference range and does it require treatment?
In a 26-year-old woman with a testosterone level of 72 ng/dL, what does this result indicate?
In a 45-year-old female with estradiol 147 pg/mL, total testosterone 6 ng/dL, and progesterone 0.8 ng/mL, are these hormone levels normal and what treatment, if any, is recommended?
Is a testosterone level of 7 ng/dL considered low for a woman given the reference range of 4–50 ng/dL?
What is the appropriate evaluation and management for a 26‑year‑old woman with an elevated total testosterone level of 72 ng/dL?
What are the differences between the selective adrenergic agents (dobutamine and phenylephrine) and the non‑selective adrenergic agents (epinephrine and norepinephrine)?
Is ursodeoxycholic acid and escitalopram safe to use during pregnancy?
What disease and associated symptoms would warrant prescribing nitrofurantoin 100 mg twice daily for 5 days, phenazopyridine 200 mg three times daily for 2 days, and omeprazole taken on an empty stomach each morning?
What is the purpose and proper use of nitrofurantoin 100 mg twice daily for five days, phenazopyridine 200 mg three times daily for two days, and omeprazole taken on an empty stomach each morning in treating acute uncomplicated cystitis?
When is intravenous iron indicated and what are the recommended dosing regimens and monitoring procedures?
What is the normal reference range for serum sex hormone‑binding globulin (SHBG) in a 35‑year‑old woman, and how should it be interpreted alongside a total testosterone level of 32.5 ng/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.